Skip to main content
Fig. 7 | Journal of Experimental & Clinical Cancer Research

Fig. 7

From: Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer

Fig. 7

CYP19A1 inhibits CD8+ T cells through upregulation of PD-L1, IL-6 and TGF-β. A Correlations of CYP19A1 with PD-L1, IL-6 and TGF-β expression levels in GEPIA database. B and C IL-6 and TGF-β expression levels in HT29 and HCT116 cells were measured by qPCR. D PD-L1 expression level was determined by flow cytometry. E CFSE dilution was used to measure the proliferation of CD8+ T cells. F GzmB and IFN-γ in CD8+ T cells were determined by qPCR. G Transwell migration analysis of endothelial cells and pericyte cells treated with the conditioned medium from the above treated-HT29 cells. The values are presented as the mean ± standard error of the mean, n = 5. **, P < 0.01 vs. control. ##, P < 0.01 vs. si-Scram. ^, P < 0.01; ^^, P < 0.01 vs. CYP19A1

Back to article page